Combination of medullary thyroid cancer and renal cell carcinoma in one patient

Patients who received treatment for the first malignant neoplasm remain in the group at increased risk of developing a second primary tumor throughout their later life. A rare case of medullary thyroid cancer and renal cell carcinoma of the kidney is described in one patient. Medullary thyroid cance...

Full description

Bibliographic Details
Main Authors: Yuliya A. Dolinskaya, Sergey P. Shevchenko, Vladimir N. Maksimov, Elena N. Voropaeva, Oksana D. Rymar
Format: Article
Language:Russian
Published: Endocrinology Research Centre 2018-06-01
Series:Клиническая и экспериментальная тиреоидология
Subjects:
Online Access:https://cet-endojournals.ru/ket/article/viewFile/9259/7254
id doaj-448c7f3360ab4f80bced359c2c47a4bb
record_format Article
spelling doaj-448c7f3360ab4f80bced359c2c47a4bb2021-06-02T19:26:28ZrusEndocrinology Research CentreКлиническая и экспериментальная тиреоидология1995-54722310-37872018-06-01141343810.14341/ket92598462Combination of medullary thyroid cancer and renal cell carcinoma in one patientYuliya A. Dolinskaya0Sergey P. Shevchenko1Vladimir N. Maksimov2Elena N. Voropaeva3Oksana D. Rymar4Institution of Internal and Preventive MedicineNovosibirsk State UniversityInstitution of Internal and Preventive MedicineInstitution of Internal and Preventive MedicineInstitution of Internal and Preventive MedicinePatients who received treatment for the first malignant neoplasm remain in the group at increased risk of developing a second primary tumor throughout their later life. A rare case of medullary thyroid cancer and renal cell carcinoma of the kidney is described in one patient. Medullary thyroid cancer is an orphan disease. The patient and his first-line relatives underwent molecular-genetic testing, the presence of a hereditary form of medullary cancer was excluded. During the observation, malignant kidney formation was detected, and surgical treatment was performed. The patient because of treatment and surveillance does not have data for the progression of thyroid cancer and kidney cancer, compensation for concomitant diseases has been achieved. When observing patients with medullary thyroid cancer, it is necessary to use the existing modern diagnostic arsenal, including positron emission tomography, since patients remain in the group at increased risk of disease progression and development of the second tumor throughout the entire subsequent life. In addition, this case clearly illustrates the need for a routine study of calcitonin as a diagnostic marker for the progression of medullary thyroid cancer.https://cet-endojournals.ru/ket/article/viewFile/9259/7254medullary thyroid cancerrenal cancercase report
collection DOAJ
language Russian
format Article
sources DOAJ
author Yuliya A. Dolinskaya
Sergey P. Shevchenko
Vladimir N. Maksimov
Elena N. Voropaeva
Oksana D. Rymar
spellingShingle Yuliya A. Dolinskaya
Sergey P. Shevchenko
Vladimir N. Maksimov
Elena N. Voropaeva
Oksana D. Rymar
Combination of medullary thyroid cancer and renal cell carcinoma in one patient
Клиническая и экспериментальная тиреоидология
medullary thyroid cancer
renal cancer
case report
author_facet Yuliya A. Dolinskaya
Sergey P. Shevchenko
Vladimir N. Maksimov
Elena N. Voropaeva
Oksana D. Rymar
author_sort Yuliya A. Dolinskaya
title Combination of medullary thyroid cancer and renal cell carcinoma in one patient
title_short Combination of medullary thyroid cancer and renal cell carcinoma in one patient
title_full Combination of medullary thyroid cancer and renal cell carcinoma in one patient
title_fullStr Combination of medullary thyroid cancer and renal cell carcinoma in one patient
title_full_unstemmed Combination of medullary thyroid cancer and renal cell carcinoma in one patient
title_sort combination of medullary thyroid cancer and renal cell carcinoma in one patient
publisher Endocrinology Research Centre
series Клиническая и экспериментальная тиреоидология
issn 1995-5472
2310-3787
publishDate 2018-06-01
description Patients who received treatment for the first malignant neoplasm remain in the group at increased risk of developing a second primary tumor throughout their later life. A rare case of medullary thyroid cancer and renal cell carcinoma of the kidney is described in one patient. Medullary thyroid cancer is an orphan disease. The patient and his first-line relatives underwent molecular-genetic testing, the presence of a hereditary form of medullary cancer was excluded. During the observation, malignant kidney formation was detected, and surgical treatment was performed. The patient because of treatment and surveillance does not have data for the progression of thyroid cancer and kidney cancer, compensation for concomitant diseases has been achieved. When observing patients with medullary thyroid cancer, it is necessary to use the existing modern diagnostic arsenal, including positron emission tomography, since patients remain in the group at increased risk of disease progression and development of the second tumor throughout the entire subsequent life. In addition, this case clearly illustrates the need for a routine study of calcitonin as a diagnostic marker for the progression of medullary thyroid cancer.
topic medullary thyroid cancer
renal cancer
case report
url https://cet-endojournals.ru/ket/article/viewFile/9259/7254
work_keys_str_mv AT yuliyaadolinskaya combinationofmedullarythyroidcancerandrenalcellcarcinomainonepatient
AT sergeypshevchenko combinationofmedullarythyroidcancerandrenalcellcarcinomainonepatient
AT vladimirnmaksimov combinationofmedullarythyroidcancerandrenalcellcarcinomainonepatient
AT elenanvoropaeva combinationofmedullarythyroidcancerandrenalcellcarcinomainonepatient
AT oksanadrymar combinationofmedullarythyroidcancerandrenalcellcarcinomainonepatient
_version_ 1721401591297212416